Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Hilary Seay

Nurse Practitioner, Pediatrics Mobile, AL Nurse Practitioner

NPI 1073852679 CMS profile 11136198

5675 Three Notch Rd, Suite C, Mobile, AL 36619

Open in the dashboard

General payments

$5,179

337 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Hilary Seay of Mobile, AL is reported in the CMS Open Payments database as having received $5,179 across 337 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Nurse Practitioner, Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $729 44
2024 General $1,173 77
2023 General $1,041 73
2022 General $1,200 78
2021 General $1,037 65

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Hilary Seay
  • Nurse Practitioner, Pediatrics median
  • Middle half of Nurse Practitioner, Pediatrics
  • National median

In program year 2025, general payments to Hilary Seay were reported at $729. Among 7,458 Nurse Practitioner, Pediatrics profiles paid that year, the median was $93 and the middle half received between $35 and $201.

Show as a table
Year Hilary Seay Nurse Practitioner, Pediatrics median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $1,037 $60 $23–$142 $132
2022 $1,200 $72 $27–$161 $149
2023 $1,041 $89 $35–$185 $160
2024 $1,173 $93 $34–$199 $164
2025 $729 $93 $35–$201 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Corium, Inc. $1,155 57 payments
  2. Tris Pharma Inc $1,100 84 payments
  3. Supernus Pharmaceuticals, Inc. $1,099 82 payments
  4. Neos Therapeutics, LP $736 51 payments
  5. Ironshore Pharmaceuticals Inc. $626 34 payments
  6. Collegium Pharmaceutical, Inc. $188 10 payments
  7. Takeda Pharmaceuticals U.S.A., Inc. $150 12 payments
  8. Adlon Therapeutics L.P. $64 4 payments
  9. Vertical Pharmaceuticals, LLC $61 3 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $5,179 337 payments
Products named General payments · program years 2021–2025
  1. Azstarys $1,155 57 payments
  2. Dyanavel XR Adhd $700 55 payments
  3. Qelbree Viloxazine Hydrochloride $620 44 payments
  4. Adzenys XR-ODT $481 29 payments
  5. QELBREE Psychology $473 37 payments
  6. Dyanavel XR Adhd $335 24 payments
  7. JORNAY PM Central Nervous System Stimulant $334 17 payments
  8. JORNAY PM Central Nervous Stimulant ADHD $291 17 payments
  9. COTEMPLA XR-ODT $268 24 payments
  10. Jornay PM Adhd $188 10 payments
  11. Other $352 26 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

337 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Pediatrics in Alabama

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record